Pathstone Family Office, LLC Navidea Biopharmaceuticals, Inc. Call Options Transaction History
Pathstone Family Office, LLC
- $15.6 Billion
- Q3 2023
Call Options
0 transactions
| Quarter | Operation | Price Per call | calls change | calls Held | SEC Form |
|---|
Others Institutions Holding NAVB
# of Institutions
2Shares Held
10.4KCall Options Held
0Put Options Held
0About NAVIDEA BIOPHARMACEUTICALS, INC.
- Ticker NAVB
- Exchange NYSE
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 32,150,900
- Description
- Navidea Biopharmaceuticals, Inc., a biopharmaceutical company, focuses on the development and commercialization of precision immunodiagnostic agents and immunotherapeutics. It operates through two segments, Diagnostic Substances and Therapeutic Development Programs. The company develops Manocept platform to target the CD206 mannose receptor expr...